Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 11:13:40.
doi: 10.1186/s40545-020-00208-4. eCollection 2020.

Tackling the blind spot of poor-quality medicines in Universal Health Coverage

E S F Orubu  1   2 , C Ching  2 , M H Zaman  2 , V J Wirtz  3
Affiliations
Review

Tackling the blind spot of poor-quality medicines in Universal Health Coverage

E S F Orubu et al. J Pharm Policy Pract. .

Abstract

Background: Universal Health Coverage (UHC) is challenged by the prevalence of poor-quality medicines, those that either do not meet required specifications (substandard) or are outrightly fraudulent (falsified), especially in Low- and Middle-Income Countries, LMICs. Whereas poor-quality medicines are a significant burden in these countries, medicine quality still remains a neglected component of UHC programs. This article describes key barriers to quality medicines and presents five select approaches leveraging the scale-up of UHC for medicine quality assurance.

Main body: Barriers to medicine quality assurance, while numerous, are described in five key inter-related domains as: low political priority, weak regulatory systems capacity, poor access to accredited facilities and licensed outlets, medicine manufacturing and other supply-chain challenges, and lack of public awareness. Five select approaches for leveraging the scale-up of UHC for medicine quality assurance in LMICs are (1): political commitment (2) strengthening the capacity of regulatory authorities and investment in detection technologies as part of national security (3); licensing of medicines outlets and expanding pharmacovigilance (4); strengthening the supply-chain; and (5) public awareness and participation.

Conclusions: Unchecked, poor-quality medicines can jeopardize UHC. National governments in LMICs need to prioritize medicine quality assurance through enforcing policies, regulatory strengthening and investments in technologies. Healthcare facilities and insurance schemes under UHC also play critical roles through incorporating medicine quality assurance into procurement practices and by promoting awareness among beneficiaries. Tackling medicine quality with a committed systems approach will enhance progress towards UHC implementation.

Keywords: Falsified; Medicine; Poor-quality; Quality assurance; Substandard; Universal Health Coverage.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

References

    1. WHO . Universal health coverage (UHC) 2020.
    1. Hogan DR, Stevens GA, Hosseinpoor AR, Boerma T. Monitoring universal health coverage within the Sustainable Development Goals: development and baseline data for an index of essential health services. Lancet Glob Health. 2018;6(2):e152–e168. - PubMed
    1. United Nations Statistics Division . Global indicator framework for the Sustainable Development Goals and targets of the 2030 Agenda for Sustainable Development. 2020. p. 21.
    1. Management Sciences for Health . MDS-3: Managing access to medicines and health technologies. 2012.
    1. WHO . Local production for access to medical products: developing a framework to improve public health. Genève (Suisse): OMS, World Health Organization; 2012.